Tumor and blood samples were analyzed by flow cytometry, immunohistochemistry, transcriptome and cytokine profiling. Cabozantinib-related effects were validated in a colorectal cancer PDX model.
[Clinical Cancer Research]
Sorry, but the selected Zotpress account can't be found.
